Fred Graff Insider Trading $REPH Recro Pharma, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Fred Graff.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Fred Graff. Fred Graff is Chief Commercial Officer in Recro Pharma, Inc. ($REPH).
Fred Graff in Recro Pharma, Inc.
Trading Symbol: REPHIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Fred Graff: Chief Commercial Officer
Holdings: 28,900 shares
Current Value: $232,645
Latest Transaction: Jan 22 2018
$REPH Market Capitalization: $98.40M
$REPH Previous Close: $8.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Fred Graff in Recro Pharma, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 22 2018 | REPH | Recro Pharma, Inc. | Graff Fred | Chief Commercial Of ... | Option Exercise | M | 0.00 | 6,000 | 0 | 18,000 | |
Jan 22 2018 | REPH | Recro Pharma, Inc. | Graff Fred | Chief Commercial Of ... | Payment of Exercise | F | 8.89 | 1,817 | 16,153 | 27,083 | 28.9 K to 27.1 K (-6.29 %) |
Jan 22 2018 | REPH | Recro Pharma, Inc. | Graff Fred | Chief Commercial Of ... | Buy | M | 0.00 | 6,000 | 0 | 28,900 | 22.9 K to 28.9 K (+26.20 %) |
Jan 04 2018 | REPH | Recro Pharma, Inc. | Graff Fred | Chief Commercial Of ... | Option Exercise | A | 9.04 | 25,800 | 233,232 | 25,800 | |
Jan 04 2018 | REPH | Recro Pharma, Inc. | Graff Fred | Chief Commercial Of ... | Grant | A | 0.00 | 12,900 | 0 | 22,900 | 10 K to 22.9 K (+129.00 %) |
Oct 02 2017 | REPH | Recro Pharma, Inc. | Graff Fred | Chief Commercial Of ... | Buy | M | 0.00 | 2,000 | 0 | 10,000 | 8 K to 10 K (+25.00 %) |
Jan 20 2017 | REPH | Recro Pharma, Inc. | Graff Fred | Chief Commercial Of ... | Option Exercise | A | 0.00 | 24,000 | 0 | 24,000 | |
Jan 20 2017 | REPH | Recro Pharma, Inc. | Graff Fred | Chief Commercial Of ... | Option Exercise | A | 7.33 | 34,800 | 255,084 | 34,800 | |
Jun 02 2016 | REPH | Recro Pharma, Inc. | Graff Fred | Chief Commercial Of ... | Buy | P | 8.46 | 8,000 | 67,707 | 8,000 | 0 to 8 K |
Feb 18 2016 | REPH | Recro Pharma, Inc. | Graff Fred | Chief Commercial Of ... | Option Exercise | A | 6.10 | 91,000 | 555,100 | 91,000 |
Page: 1